Changjiang Runfa Health Industry Co., Ltd.

SZSE:002435.SZ

4.29 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 3,238.1063,469.5584,369.8154,240.5845,038.4674,673.7572,986.9482,115.0041,064.7091,227.8821,154.8441,174.5071,119.746839.494748.501894.548596.206
Cost of Revenue 2,158.0062,309.9862,442.091,853.3451,943.761,788.5821,628.3861,421.435914.7451,079.8561,011.2941,048.0851,007.063736.444640.941793.551513.107
Gross Profit 1,080.11,159.5721,927.7252,387.2393,094.7082,885.1751,358.561693.569149.963148.026143.55126.422112.683103.05107.56100.99683.099
Gross Profit Ratio 0.3340.3340.4410.5630.6140.6170.4550.3280.1410.1210.1240.1080.1010.1230.1440.1130.139
Reseach & Development Expenses 163.76647.92371.0168.731122.04596.74969.04250.2892.8633.6582.3768.37300000
General & Administrative Expenses 68.6578.64271.048-24.125-78.28165.91233.22649.4313.03410.58611.04811.2121.49419.42316.14113.0448.673
Selling & Marketing Expenses 737.867718.8131,391.8451,739.4542,310.0682,049.632776.908153.08735.78237.61535.74930.56724.65717.32117.21816.73214.757
SG&A 806.517797.4551,462.8941,715.3292,231.7862,115.544810.133202.51848.81648.20146.79741.77746.15136.74433.35929.77523.43
Other Expenses 0.057126.097120.669146.234236.3050.8892.58314.9133.4041.5592.9272.1821.1311.9720.7873.037.913
Operating Expenses 1,084.26971.4751,654.5721,930.2942,590.1362,340.699956.554331.53970.08369.85164.59858.61247.54139.21734.89431.58924.638
Operating Income -783.715172.873432.684505.235719.506487.813375.489337.97446.84355.49260.28949.66654.83348.0851.35442.58443.616
Operating Income Ratio -0.2420.050.0990.1190.1430.1040.1260.160.0440.0450.0520.0420.0490.0570.0690.0480.073
Total Other Income Expenses Net 0.057-106.496-839.866-214.205-1,051.553-55.774-23.936-10.196-29.737-21.148-16.09-16.271-9.196-13.78-20.57-23.827-7.054
Income Before Tax -783.65866.377-407.182291.03-332.047488.702378.071351.83450.14357.02662.86251.53955.94750.05252.09645.5851.407
Income Before Tax Ratio -0.2420.019-0.0930.069-0.0660.1050.1270.1660.0470.0460.0540.0440.050.060.070.0510.086
Income Tax Expense 24.3125.0448.6647.18979.42793.68747.4652.5746.478.89911.2729.1149.9078.3398.9288.2212.549
Net Income -766.72941.333-415.843247.69-411.474367.13334.694160.14843.67348.12751.58942.42546.0441.71443.16837.3638.31
Net Income Ratio -0.2370.012-0.0950.058-0.0820.0790.1120.0760.0410.0390.0450.0360.0410.050.0580.0420.064
EPS -0.620.033-0.340.2-0.330.30.270.190.0860.0940.10.130.0920.0940.120.0990.15
EPS Diluted -0.620.033-0.340.2-0.330.30.270.190.0860.0940.10.130.0920.0940.120.0990.15
EBITDA 175.303321.348571.771635.605868.801722.363544.326467.204130.29122.688117.265101.491.81785.86593.5887.43967.919
EBITDA Ratio 0.0540.0930.1310.150.1720.1550.1820.2210.1220.10.1020.0860.0820.1020.1250.0980.114